NCT02867098View on ClinicalTrials.gov

XmAb5871 Bioavailability Study

PHASE1CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 21, 2016

Study Completion Date

October 21, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

XmAb5871

Trial Locations (1)

91206

PAREXEL, Early Phase Clinical Unit-Los Angeles, Glendale

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Parexel

INDUSTRY

lead

Xencor, Inc.

INDUSTRY